Chiron Investment Management’s Cellectis CLLS Stock Holding History

Chiron Investment Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$125K	Buy	+4,616	New	+$104K	0.02%	89

Other funds holding CLLS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Chiron Investment Management's CLLS Position: Q4 2020 in Review

Chiron Investment Management opened a new position in Cellectis (CLLS) in Q4 2020: 4,616 shares worth $125K. The stake represents 0.02% of the portfolio and ranks #89 among its holdings.

90 funds tracked by Wall St. Rank hold CLLS as of Q4 2020.

Chiron Investment Management held 4,616 shares of Cellectis worth $125K as of Q4 2020.
Cellectis was a new Chiron Investment Management position in Q4 2020.
Cellectis made up 0.02% of Chiron Investment Management's portfolio in Q4 2020, its #89 holding.
90 funds tracked by Wall St. Rank held Cellectis as of Q4 2020.

Based on Chiron Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.